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Abstract
Background: Retinal ganglion cell (RGC) death is the final consequence of many blinding diseases,
where there is considerable variation in the time course and severity of RGC loss. Indeed, this
process appears to be influenced by a wide variety of genetic and environmental factors. In this
study we explored the genetic basis for differences in ganglion cell death in two inbred strains of
mice.
Results: We found that RGCs are more susceptible to death following optic nerve crush in
C57BL/6J mice (54% survival) than in DBA/2J mice (62% survival). Using the Illumina Mouse-6
microarray, we identified 1,580 genes with significant change in expression following optic nerve
crush in these two strains of mice. Our analysis of the changes occurring after optic nerve crush
demonstrated that the greatest amount of change (44% of the variance) was due to the injury itself.
This included changes associated with ganglion cell death, reactive gliosis, and abortive
regeneration. The second pattern of gene changes (23% of the variance) was primarily related to
differences in gene expressions observed between the C57BL/6J and DBA/2J mouse strains. The
remaining changes in gene expression represent interactions between the effects of optic nerve
crush and the genetic background of the mouse. We extracted one genetic network from this
dataset that appears to be related to tissue remodeling. One of the most intriguing sets of changes
included members of the crystallin family of genes, which may represent a signature of pathways
modulating the susceptibility of cells to death.
Conclusion: Differential responses to optic nerve crush between two widely used strains of mice
were used to define molecular networks associated with ganglion cell death and reactive gliosis.
These results form the basis for our continuing interest in the modifiers of retinal injury.
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Background
For many ocular diseases that result in the loss of vision,
the death of retinal ganglion cells (RGCs) is the final com-
mon pathway. Glaucoma is one such ocular disease where
the sporadic family history and the presence of significant
risk factors in select populations suggest that the suscepti-
bility of RGC death is a complex trait [1,2]. For example,
elevation in intraocular pressure (IOP) in open angle
glaucoma is strongly associated with an increased likeli-
hood of RGC death. Lowering IOP almost always has the
beneficial effect of sparing RGCs. However, some patients
with normal or even low IOP develop glaucoma with
associated RGC death [3,4]. The reverse is also true:
selected populations of people have very high IOPs and
yet do not develop glaucoma or lose RGCs [3]. The fact
that some patients with low IOPs develop glaucoma while
others with high IOPs do not has led to the hypothesis
that critical genetic sequence variants segregating human
populations influence the relative susceptibility or resist-
ance to ganglion cell death [5]. One efficient way to meas-
ure the influence of sequence variants on complex traits is
to compare different inbred strains of mice. For example,
Nickells and colleagues [6] studied the differential sur-
vival of RGCs in 15 highly diverse strains of mice follow-
ing optic nerve crush, finding that ganglion cells in some
strains were highly susceptible whereas other strains were
relatively resistant. This difference demonstrates the
importance of genetic background on the complex proc-
ess of ganglion cell death. Defining the genomic differ-
ences between these strains has the potential to lead to
novel treatments to prevent ganglion cell loss and pre-
serve vision.
One obvious approach to examining the molecular differ-
ences that underlie the susceptibility or resistance of gan-
glion cells to injury is to use microarray methods to
profile the transcriptomes of inbred strains of mice. A con-
siderable amount of published microarray data describes
the retina's response to injury in different rodent strains.
When one looks across all of these studies, there is a gen-
eral agreement that changes in gene expression are classic
responses of the central nervous system (CNS) to injury
[7]. For example, genes that are associated with reactive
gliosis, such as Gfap, are often upregulated, whereas neu-
ronal marker genes such as Thy1 are often downregulated
[7-13]. Some studies have gone further, focusing on the
response of the inner retina to look at regional changes
[14]; other studies have used laser-capture microdissec-
tion to examine expression profiles of isolated RGCs [15].
The common responses to injury can be observed in a
variety of different types of insult to the eye. Earlier work
in our laboratory [7] found that many of the changes
resulting from mechanical injury to the eye are similar to
changes in other models of retinal injury, including
ischemia [16], elevated intraocular pressure [8], photoco-
agulation [17], and photo-oxidative stress [18]. These
common responses across different rodent species with
different types of insult are interesting, however since they
are common to susceptible and resistant strains they are of
little use in determining the underling susceptibility to
insult.
In this study, we compared the response of the retina to
optic nerve crush in C57BL/6J and DBA/2J mice. Both of
these strains are widely used in vision research. There is an
extensive catalogue of ocular phenotypes and genetic
modifications for both strains [19]. Also, these two strains
are the parents of the BXD recombinant inbred (RI) strain
set, which has been used for more than a decade to study
the genetic basis of variations in the structure of the eye,
retina, and central visual system [20,21]. We have com-
prehensive gene expression data for the eyes of most of
these BXD strains [20] and therefore can use all of these
array and phenotype datasets to map sequence variants
that influence entire genetic networks regulating the
response of the retina to injury.
Results and Discussion
To study molecular mechanisms underlying differential
response of the retina to injury, we exploited two mouse
strains, C57BL/6J and the DBA/2J. The first part of this sec-
tion covers the differential effect of optic nerve crush on
ganglion cell survival. For the anatomical studies the reti-
nas were examined 30 days after the optic nerve crush.
This extended period of time allowed us to have a clear
picture of the long-term effects of the insult to the optic
nerve. In the second part, we describe changes in the tran-
scriptome at two time points after the crush. To define
potential changes in the transcriptome that underlie the
long-term effects of optic nerve crush, the microarray sam-
ples were taken at 2 and 5 days after optic nerve crush. We
have supplemented the analysis by generating microarray
data of cultured astrocytes from C57BL/6J and DBA/2J
strains and by a meta-analysis of array data from existing
public databases.
Retinal Ganglion Cell Loss After Optic Nerve Crush
To define difference in the response of the C57BL/6J and
DBA/2J mice to optic nerve crush, we examined the reti-
nas of normal mice and mice 30 days after optic nerve
crush (Figure 1). The most obvious change was a dramatic
decrease in the number of NeuN-stained cells in the reti-
nas of both strains when the nerve was crushed. We
counted the number of NeuN-labeled cells in the gan-
glion cell layers of control retinas and retinas from ani-
mals 30 days after optic nerve crush for both the C57BL/
6J mouse and the DBA/2J mouse. We sampled between 14
and 18 fields from 5 retinas for each strain to define the
density of NeuN positive cells per mm2 (see methods sec-
tion). In the control C57BL/6J mice, the average numberBMC Neuroscience 2009, 10:90 http://www.biomedcentral.com/1471-2202/10/90
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of NeuN-positive cells (ganglion cells plus the population
of displaced amacrine cells) was 5012 cells/mm2 with a
standard error of 317 cells/mm2. The control DBA/2J mice
had 4295 cells/mm2 with a standard error of 187 cells/
mm2. This difference in the density of NeuN-positive cells
between the two strains is significant using the student t-
test (p < 0.04).
In our data, we see a significant difference in the number
of NeuN-positive cells between the C57BL/6J and the
DBA/2J strains. When one examines the literature for
comparative numbers, Williams et al. [22] calculated the
axon number to be a mean of 54,600 ganglion cells per
retina for the C57BL/6J strain (pooled data from pig-
mented and coisoenic albino mice) and 63,400 ganglion
cells per retina for the DBA/2J strain. If this is converted to
cell density per mm2 the numbers are 2,884 cells/mm2 for
the C57BL/6J strain and 3,254 cells/mm2 for the DBA/2J
strain. In the study by Buckingham et al. [23] they used
NeuN staining and cell counting similar to that used in
the present study and they arrived at very similar numbers
(see Figure 2 in Buckingham et al., 2008). Extrapolating
from their graph they see 4,800 cells per mm2 for C57BL/
6J and 4,200 cells per mm2 for the DBA/2J mouse [23].
These numbers are very similar to the ones from the
present study. It is hard to say why there are differences
between studies. The most parsimonious explanation is
that differences seen from study to study may be related to
the sampling method.
After the optic nerve crush, the average density of NeuN-
positive cells decreased to 2694 cells/mm2 in C57BL/6J
retina and to 2677 cells/mm2 in DBA/2J retina. To deter-
mine if there is a difference in the response of the retinal
ganglion cells to injury, we calculated the percent survival
for each optic nerve crushed retina, dividing the density of
retinal ganglion cells in that retina by the average density
in the control retina of the same strain. The disparity in
survival between the two strains is shown in Figure 2.
There was a 54% survival of NeuN-positive cells in the
C57BL/6J mouse, while the DBA/2J mice had a 62% sur-
Quantification of loss of retinal ganglion cells Figure 2
Quantification of loss of retinal ganglion cells. The per-
cent survival of retinal ganglion cells following optic nerve 
crush (ONC) is shown for two strains of mice, C57BL/6J 
(B6) and DBA/2J (D2). The data points represent the percent 
survival for each of the retinas that received a crush of the 
optic nerve. The means of each group are indicated by the 
horizontal lines. This number was calculated by dividing the 
density of NeuN-positive cells optic nerve crush retinas by 
the average density of the control retinas of the same strain. 
There was a statistically significant (t-test, p < 0.01) differ-
ence in the survival of NeuN-positive cells, with 54% survival 
in the C57BL/6J mouse and 62% survival in the DBA/2J 
mouse.
Effects of optic nerve crush on the retinas of C57BL/6 and  DBA/2J mice Figure 1
Effects of optic nerve crush on the retinas of C57BL/6 
and DBA/2J mice. The effect of optic nerve crush on the 
survival of retinal ganglion cells is shown in 4 panels. C57BL/6 
retinas are shown in A (control) and B (optic nerve crush); 
DBA/2J retinas appear in C (control) and D (optic nerve 
crush). Note the significant decrease in ganglion cell staining 
after optic nerve crush. Ganglion cells were stained with 
NeuN. All panels are at 40× magnification. The scale bar in 
panel D represents 50 μm.BMC Neuroscience 2009, 10:90 http://www.biomedcentral.com/1471-2202/10/90
Page 4 of 15
(page number not for citation purposes)
vival of neurons. This difference in NeuN-labeled cell loss
is significant using a student t-test (p < 0.01). Since we
used NeuN to label cells in the ganglion cell layer, it is
possible that displaced amacrine cells were included in
our counts. The displaced amacrine cells represent a
diverse population of cells [24,25]. There are strain differ-
ences in the number of amacrine cells in the mouse
[26,27]. The strain differences include the number of
ChaT-positive displaced amacrine cells [26]. In the
C57BL/6 mouse the ChaT-positive amacrine cells are esti-
mated to be 19% of the total population of displaced
amacrine cells [28]. Thus, the neurons surviving in the
ganglion cell layer may include both ganglion cells and
some displaced amacrine cells. It is worth noting that
Buckingham et al. [23] directly addressed this question
and found that a consistent proportion of ChaT-positive
displaced amacrine cells expressed detectible levels of
NeuN.
When we compare our data to others, we find that Li et al.
[6] did not observe a statistically significant difference in
survival following optic nerve crush between the C57BL/
6J mouse and the DBA/2J mouse. It is interesting to note
that the DBA/2J trended higher than the C57BL/6J (see
Figure 1 of Li et al.) [6]. In our study, we found a modest,
but statistically significant differences between the two
strains. This could be due to differences in techniques to
crush the optic nerve, differences in staining, or the fact
that we used control mice and Li et al. [6] used the con-
tralateral eye as a control for optic nerve crush [6]. The
small difference in survival we observe may have signifi-
cant ramifications to our microarray studies and will
allow us to map genetic networks using the BXD recom-
binant inbred mice along with the powerful bioinformat-
ics tools in GeneNetwork http://genenetwork.org[29].
Changes in the Transcriptome After Optic Nerve Crush in 
the C57BL/6J and DBA/2J Strains
Microarrays were run on both the C57BL/6J and the DBA/
2J strains with RNA isolated from control mice and mice
2 and 5 days after optic nerve crush. The first step in the
data analysis was to select a set of genes for analysis. For
this analysis we used Significance Analysis of Microarrays
(SAM, Stanford University, http://www-stat.stanford.edu/
~tibs/SAM). We made five biologically meaningful com-
parisons to define groups of genes that change in the two
strains following optic nerve crush. The first comparison
was to define genes that had significantly different levels
of expression between the two normal retinas, control
C57BL/6J retina and control DBA/2J retina (522 probes).
The next four comparisons were done to select genes that
were differentially expressed after optic nerve crush, com-
paring the control samples to the 2-day crush and 5-day
crush samples of each strain for both the C57BL/6J retina
and DBA/2J retina. This will define genes that are chang-
ing following optic nerve crush: C57BL/6J control versus
2 day after injury (49 probes) and versus 5 days after
injury (1007 probes) and DBA/2J control versus 2 days
after injury (0 probes) and 5 days after injury (52 probes).
After the duplicate probes were scrubbed, a total of 1,580
probes from the Illumina array were selected with a false
discovery rate less than 0.03. The next phase of the analy-
sis was to define functional clusters of genes using a prin-
cipal component analysis. Using the CLUSFAVOR v6.07
program [30], we identified clusters of genes based on
their expression patterns (Figure 3). This analysis resulted
in 5 eigenvectors dividing the dataset into 10 groups, with
a positive and negative component for each vector (Figure
3). The 10 clusters account for all of the variability in the
dataset. A number of different data-mining tools were
used to extract biologically meaningful information from
these clusters. The web-based software used included the
National Center for Biotechnology Information web site
for PubMed [31] and Entrez Gene databases [32], Chili-
bot for searching PubMed relationships [33], Genomatix
for searching for possible transcription factors [34], Trans-
fac 7.0 for transcription factor mining [35], UCSC
Genome Bioinformatics for its genome browser [36],
WebGestalt for its annotation abilities [37], Gensat [38],
and GeneNetwork [29].
To complement this work, we generated a microarray
dataset for astrocytes isolated from the C57BL/6J and the
DBA/2J cortices. This astrocyte data set was used to gener-
ate three lists of transcripts. We used two independent
approaches to create the lists. The first approach com-
pared the average expression of all of transcripts in the 6
(3 C57BL/6J and 3 DBA/2J) astrocyte micorarrays to the
average of the gene expression in the 6 normal retina sam-
ples (3 C57BL/6J and 3 DBA/2J). The first list is a group of
325 genes, which were 20-fold enriched in the astrocyte
sample relative to the retina. We considered this list of
genes to be an astrocyte signature. Of these 325 genes, 36
were present in the selected genes of the optic nerve crush
dataset (See additional file 1: Genes with ≥ 20 fold change
between astrocyte and control retina). The second list of
genes, totaling 379, contained transcripts that were 20-
fold enriched in the retina relative to the astrocyte sample,
was classified as a non-astrocyte signature. Of these 379
genes, 44 were present in the optic nerve crush dataset
(See additional file 2: Genes with ≤ -20 fold change
between astrocyte and control retina). The third list of
genes, totaling 934, was created to identify transcripts that
were differentially expressed in cultured C57BL/6J astro-
cytes relative to DBA/2J astrocytes. In this list, 321 genes
were more highly expressed in C57BL/6J astrocytes and
613 genes were more highly expressed in DBA/2J astro-
cytes. Of the 934 genes, 186 were present in the optic
nerve crush dataset (See additional file 3: C57BL/6J astro-
cyte vs. DBA/2J astrocyte fold change). The first two of
these three lists were combined and considered to be dif-
ferentially expressed genes between the two types of astro-BMC Neuroscience 2009, 10:90 http://www.biomedcentral.com/1471-2202/10/90
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cytes. These lists of genes were used in our analysis of the
differential response of the C57BL/6J and DBA/2J retina
to optic nerve crush.
Of the 1,580 genes in our optic nerve crush data set, 9
were selected and examined by real-time qRT-PCR. These
genes were Bcl2a1a, Chrna6, Cryaa, Crybb2, Crym, Egr1,
Gfap, Sox11, and Thy1. (See additional file 4: Oligonucle-
otides used for Real-Time qRT-PCR). In general, the pat-
terns of change for the genes monitored by real-time qRT-
PCR were similar to those observed in the averaged micro-
array datasets. The levels of Gfap were similar in compar-
ison between the control data versus 2-day injury data, as
well as the comparison between the 2-day versus 5-day
injury data. Other genes, such as Bcl2a1a, Chrna6, Cryaa,
Crybb2, Crym, and Thy1, were similar in the overall trend
from control to 5-day. However, the 2-day versus 5-day
fold change was not always in the same direction,
although the differences were small. In other cases, there
were slight differences in the fold changes, as with the
Egr1 gene, for which the real-time qRT-PCR indicated a
+0.47-fold change between the C57BL/6J 2-day versus 5-
day, the microarray result was -0.8 for the same condition.
Egr1 had a -0.35-fold change in the DBA/2J between the
2-day versus 5-day, but the microarray data yielded +1.42.
Nonetheless, the agreement between the microarray data
and real-time qRT-PCR data was excellent; indicating that
for the genes tested, the microarray provided an appropri-
ate measure of transcript level. Once the quality of the
dataset was proven, we clustered the data into groups and
began our functional analysis.
Most genes are found in the first principal component
(PC1), which contains 823 genes or 44% of the total var-
iance in the dataset. The genes in PC1 change similarly in
response to optic nerve crush in both C57BL/6J and DBA/
2J mice. As shown in Figure 3, the expression level for
genes in PC1 is approximately equal in control C57BL/6J
mice as compared to the DBA/2J mice. For PC1 positive,
the genes are downregulated 2-days after optic nerve crush
and even further downregulated 5-days after nerve crush.
A brief scan of this list of genes (See additional file 5:
Genes of principal component 1 (PC1)) reveals that many
genes, such as Thy1 and Chrna6, are genes associated with
ganglion cell injury and death. To provide an alternative
method of determining the cell types represented in PC1
positive, we examined the labeling patterns of the GEN-
SAT project web site [38]. GENSAT describes a series of
mouse strains that label sets of cells within the mouse
brain that express trans-genes under labels of gene-specific
promoter constructs. Of the 407 genes in PC1 positive, 28
were found in GENSAT, with 24 genes labeling neurons in
the brain and 5 (Npc1, Pax6, Chrnb3, Htr1d, and Chrna6)
specifically labeling axons in the optic tract. These data
indicate that PC1 positive represents genes that are
involved in the generalized decrease in neuronal markers,
specifically ganglion cells, in response to optic nerve
crush.
Principal component expression patterns Figure 3
Principal component expression patterns. The average 
gene expression profiles are shown for all 10 clusters. In 
PC1, the genes having a common expression profile in the 
C57BL/6J (B6) and DBA/2J (D2) strains are clustered. PC1 
positive represents genes in both strains that have decreased 
expression after ONC. PC1 negative has the reverse of this 
pattern, with genes increasing in expression. PC2 appears to 
represent genes that are differentially expressed in the two 
strains. These gene cluster patterns are almost mirror images 
of each other. In the remaining clusters (PC3 to PC5), very 
different patterns appear to represent interactions between 
strain differences and the effects of ONC.BMC Neuroscience 2009, 10:90 http://www.biomedcentral.com/1471-2202/10/90
Page 6 of 15
(page number not for citation purposes)
PC1 negative is also composed of genes with approxi-
mately equal expression in control C57BL/6J and DBA/2J
mice. However, both sets of genes are upregulated 2-days
after optic nerve crush and upregulated even further at 5-
days after crush (Figure 3). Genes in this group are associ-
ated not only with reactive gliosis, but with neuronal
genes in an attempt at abortive regeneration (See addi-
tional file 5: Genes of principal component 1 (PC1)).
Glial fibrillary acidic protein (Gfap), the hallmark for reac-
tive gliosis, is found in this group. Many of the genes in
this list are also markers for astrocytes. These include Gfap,
the penultimate astrocytic cytoskeletal marker, and Sox11
a known astrocyte transcription factor.
To further evaluate astrocytes marker genes, we examined
our data from cultured astrocytes from C57BL/6J and
DBA/2J mice. In one analysis, we identified genes that
were enriched in astrocytes as compared to the normal ret-
ina. Of the 36 astrocyte signature genes in our dataset of
1,580 probes, 27 are present within PC1 negative, indicat-
ing that PC1 negative contains an astrocyte signature. We
also observed genes involved in abortive regeneration,
among them growing axon protein 43 (Gap43). In exam-
ining the labeling patterns on GENSAT, 21 of the 314
genes in PC1 negative were found. Four of the PC1 nega-
tive genes (Gfap, Stat3, Ank2, and Vcam1) labeled glial
cells and two of the genes (Rax and Snap91) labeled axons
in the optic nerve. The changes observed in PC1 are com-
mon to CNS injury and are associated with the experimen-
tal condition of axonal injury caused by optic nerve crush.
This represents the most variance in the microarray data-
set and, as expected, it is due to the experimental condi-
tion. When these results are compared to other microarray
studies that examined the effects of injury in the retina,
there is a surprisingly similar list of genes. These are injury
response elements, many of which are found in the retina
after a variety of insults: ischemia [16], elevated IOP [8],
photocoagulation [17], photo-oxidative stress [18], or
direct retinal injury [7].
A recent publication [39] demonstrated the importance of
the mTOR pathway, not only in regulating axonal regen-
eration in the optic nerve, but also the survival of retinal
ganglion cells. A functional knockout of Pten, the negative
regulator of mTOR, promoted axon regeneration and the
survival of RGCs after optic nerve injury [39]. In our data-
set, we observed various changes in 25 genes within the
PTEN/mTOR pathways. Furthermore, PTEN itself is signif-
icantly upregulated and is in PC1 negative. These findings
clearly show that some of the molecular changes associ-
ated with the abortive regenerative response of the PTEN/
mTOR pathways are associated with the changes we
observed in our study. The presence of 14 of these genes
in PC1 positive indicates that they have a generalized
function in the abortive response of RGCs. Future studies
will focus on the importance of this pathway following
injury to the optic nerve.
The next principal component (PC2) appears to group
genes having different levels of expression in the two
strains of mice. PC2 contains 496 genes, which represents
23% of the variance in the dataset (See additional file 6:
Genes of principal component 2 (PC2)). The most obvi-
ous difference is the level of gene expression between the
C57BL/6J control group and the DBA/2J control group
(Figure 3). In PC2 positive (223 probes), the expression
level in C57BL/6J mice is low, while the DBA/2J mice have
high levels of expression. Furthermore, the pattern of
expression after optic nerve crush in the DBA/2J mouse is
virtually a mirror image of the C57BL/6J, with expression
decreasing 2-days after crush in the DBA/2J mice and
increasing at 2-days after crush in the C57BL/6J mice. The
PC2 negative (270 probes) is almost the reverse of the
PC2 positive component, with the expression level in
C57BL/6J mice being high and the expression level in
DBA/2J mice being low. To investigate further, we rank-
ordered the fold change between the C57BL/6J and DBA/
2J control retinas. Among the genes in PC2 in this ranked
list, 407 (82%) of the 496 probes were in the top 5% of
the most variable genes in the dataset. The most parsimo-
nious explanation is that the genes in PC2 are differen-
tially expressed in the C57BL/J and DBA/2J retinas and are
not differentially affected by optic nerve crush.
To test the hypothesis that PC2 represents genes that differ
between the two strains, we examined the Hamilton Eye
Institute Mouse Eye Database (HEIMED) on GeneNet-
work [20] to determine whether any of the genes in PC2
had a significant quantitative trait locus (QTL) or were
part of a gene network within the eye. Most of the genes
had strong cis-QTLs and were not part of an overall
genetic network. The large cis-QTL found in GeneNetwork
also points to the fact that these are genes with differences
in expression in C57BL/6J and DBA/2J mice, the parental
strains of the BXD RI strain set. The gene network analysis
and expression patterns led us to the same conclusion.
This being the case, one would predict that these differ-
ences are present in different tissues from these two
strains. Thus, we examined the microarray databases gen-
erated from C57BL/6J and DBA/2J cultured astrocytes. A
surprising number of genes are differentially expressed
between the C57BL/6J and DBA/2J astrocytes and are also
present in PC2. Of the 184 differentially expressed astro-
cyte genes found among the 1,580 genes of the Optic
Nerve Crush dataset, 162 were in PC2. This indicates that
the differential expression between the two strains is also
in astrocytes as well as the retina. Furthermore, genes that
are more highly expressed in DBA/2J astrocytes are highly
expressed in the DBA/2J retina, while genes that areBMC Neuroscience 2009, 10:90 http://www.biomedcentral.com/1471-2202/10/90
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expressed at higher levels in C57BL/6J astrocytes are
highly expressed in the C57BL/6J retina.
If PC2 represents genes that are differentially expressed,
one would predict that these genes would be expressed in
a variety of different cell types which is in fact, the case.
The genes in PC2 are found in all cell types within the
CNS. A total of 30 genes were found in the GENSAT data-
base. In PC2 positive, 3 genes (Slc7a14, Cacng5, and
Susp3) were expressed in optic nerve axons and neurons.
In PC2 negative, one gene (Casp9) was observed labeling
axons in the optic nerve. In addition, neurons were
labeled in the brain by 9 additional genes, including
Mtap1b, Lypd1, Cdon, D430039no5Rik, Dap3, Dcnq2,
Rgs16, Tac2, and Tph2. Both PC2 negative and positive
contained glial genes; 2 (Sf1 and H2-D1) were in PC2 pos-
itive and 4 (Dusp16, Fcer1g, Prom1, and Hdc) were in PC2
negative. Thus, PC2 appears to represent genes that are
differentially expressed in the C57BL/6J and DBA/2J reti-
nas. These genes do not appear to be related to any specific
cell type or function.
The most intriguing functional components are within
PC3, PC4 and PC5 (representing 33% of the variance in
the dataset) (See additional file 7: Genes of principal com-
ponent 3 through 5 (PC3-PC5)). These components rep-
resent interactions between the effects of optic nerve crush
injury and the genetic background of the two mouse
strains. If there is a signature for susceptibility or resist-
ance to ganglion cell death, or if there is a signature of
reactive gliosis, then it lies within these components.
Accordingly, we used all of the bioinformatics tools at our
disposal to identify a meaningful association between the
genes within each component. First, to determine if there
was a molecular signature of a specific cell type within any
of the PCs, we searched cell-type-specific profiles in
Cahoy et al. [40], who provided databases of genes
enriched in astrocytes, neurons, and oligodendrocytes.
We were not able to identify a signature for a specific cell
type in our microarray datasets. We also used online data-
bases NEI Bank [41], WebGestalt [37], GeneNetwork [29],
and Gene Ontology [42] but were unable to identify clear
functional associations of the genes within most of the
PC3 to PC5 clusters. In two clusters, PC3 negative and
PC5 negative, we were able to impart functional associa-
tions between the genes.
Our laboratory is one of the first to use the bioinformatics
tools on GeneNetwork to explore the functional relation-
ships between genes clustered in a microarray experiment
[43,44]. The basic hypothesis is that common regulatory
elements modulate genes to create similar changes,
thereby driving them into the same PC. A similar
approach was taken with the data in the current study. We
loaded all of the data from the individual PCs into
GeneNetwork and examined it to determine whether
genomic loci could be identified that modulated the
expression of a significant number of genes within a given
PC. We used two databases, the BXD eye database (Eye
M430v2, Sep08 RMA Database) and the BXD striatum
database (HQF BXD Striatum ILM6.1, Nov07 RankInv
Database), which was run with the same Illumina chip
used in the present study.
Only PC3 negative was found to have a series of genomic
loci modulating the expression of the genes and this was
observed only in the striatum database. Of the 57 genes in
PC3 negative, 43 were found to have common regulatory
genomic loci (Figure 4). The genes and loci shown in Fig-
ure 4 may represent a genetic network that is activated by
optic nerve crush. The bands seen in the QTL-heat map
represent the likelihood ratio statistic (LRS) and provide a
measure of the linkage between variation in the pheno-
type and genetic differences at a particular genetic locus
[45]. As the color progresses from yellow to red or from
green to blue, the LRS score increases. Some genes in PC3
negative (Anapc5, Atp6v0d1, Aup1, Bat1a, Cdk10, Csda,
Eef2, Map1lc3a, Nubp1, Prmt7, Ranbp3, Snrpa, Snrpn,
Trafd1, Trpc4ap, Tspan3, and Wrnip1) have a LRS to Chr 4
(Figure 4). Individually, the remaining genes do not have
significant LRS scores; collectively, however, they form a
pattern that reveals a modulatory genomic network (See
additional file 8: Network map of PC3 negative along with
candidate genes). This banding pattern (Figure 4) is a sig-
nature of loci modulating most of the genes in PC3 nega-
tive.
With GeneNetwork, we are able to examine the trans-
bands in the PC3 negative QTL map to define candidate
genes that may be upstream modulators of the network.
We selected two bands for this analysis, Chr. 4 and Chr.
17. Using the advance search program on GeneNetwork,
the loci were mined to identify genes within them that
have significant QTLs (Cis-QTLs). Six candidate genes
(Ltb4dh, Pole3, Rgs3, Tnc, Ugcg, and Fkbp15) with Cis-
QTLs in Chr 4 50105 MB were found. One candidate
gene, Bat1a, (See additional file 9: Candidate genes for
PC3 negative QTL) was identified for the band on Chr. 17
2740 MB. On examination, Bat1a was found to be one of
the genes within the PC3 negative gene cluster (Figure 4).
Thus, it appears that PC3 negative forms a functional gene
network with a yet unknown function. To find the func-
tion of the PC3 negative gene network, we ran the list of
genes on WebGestalt and Gene Ontology. WebGestalt
showed that 20 genes were involved in cellular metabo-
lism, with 10 of the 20 (Bat1a, Snrpa, Csda, Snrpb, Krr1,
Wrnip1, Snrpn, Prmt7, Mtdh, and Atp6v0d1) involved in
nucleic acid metabolism and 9 of the 20 (Anapc5, Cdk10,
Uble1a, Eef2, Ptp4a2, Fbxl12, Map1lc3a, Prmt7, and Eif5a)
involved in cellular macromolecule metabolism. The geneBMC Neuroscience 2009, 10:90 http://www.biomedcentral.com/1471-2202/10/90
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ontology for the group found that 4 genes (Map1lc3a,
Uble1a, Anapc5, and Fbxl12) had a biological process in
the ubiquitin cycle and 20 other genes (Cdk10, Clns1a,
Cope, Coq5, Csda, Ergic3, Etfb, Gbas, Krr1, Map1lc3a,
Mapk8ip3, Mdm1, Mtdh, Prmt7, Snrpb, Snrpn, Sv2a,
Trpc4ap, Uble1a, and Wrnip) had a cellular function relat-
ing to an intracellular membrane-bound organelle. Based
on the biological function, the genes clustered in PC3 neg-
ative appear to be related to cellular remodeling.
One intriguing finding was the presence of crystallin
genes in PC5 negative. Crystallin family members in
C57BL/6J mice respond to optic nerve crush differently
than do those in DBA/2J mice (Figure 5). This observation
led us to reanalyze the entire crystallin family. We found
that many of the crystallin family members have a similar
pattern of expression, being downregulated in the C57BL/
6J retina and upregulated in the DBA/2J retina at 2-days
after optic nerve crush. The members of the crystallin fam-
ily with this pattern of expression include Cryaa, Cryab,
Cryba1, Cryba2, Cryba4, Crybb1, Crybb2, Crybb3, Crygb,
Crygc, Crygd, and Crygs (Figure 5). Thus, it appears that a
selective group of crystallins is differentially affected by
optic nerve crush in the two strains of mice. If we examine
the HEI retina database for the genes that are differentially
modulated by optic nerve crush (see Figure 5), it is very
clear that the expression of this group of crystallins is
highly correlated across the strains in the BXD RI strain set
(Figure 6). This is a strong indicator that this subset of
crystallin genes form a genetic network within the normal
retina and the differences we observed in the parental
strains (C57BL/6J and DBA/2J) are the basis for the net-
work observed in the BXD retinas. One could argue that
this is due to lens contamination or an oddity of the ret-
ina; however, this is not the case. If we examine the BXD
hippocampus dataset in GeneNetwork, then we can see a
similar highly correlated network (Table 1). This would
exclude the possibility of contamination by the lens, for it
is not present within the brain. Furthermore, the crystallin
network does not appear to be specific to the BXD RI
strain set. A similar crystallin network is also observed in
the LXS RI hippocampus (Table 1). Thus, the crystallin
network is found in the hippocampus of two different RI
strain sets, the BXD and the LXS. The crystallin network is
not an artifact of the microarray platform being used. In
the BXD retina dataset we used the Illumina Sentrix
Mouse 6 version 2.0 array, in the BXD hippocampus data-
set we used the Affymetrix Mouse Expression 430 v2.0
array, and in the LXS hippocampus we used the Illumina
Sentrix Mouse 6 version 1.0 array. This indicates that crys-
tallin network is found using very different microarray
platforms and is not due to an inherent complication that
is platform specific. Finally, this crystallin network is not
generalized to all CNS structures. If we examine the BXD
cerebellum dataset or the BXD striatum dataset in
GeneNetwork, there is no correlation between these crys-
tallin family members.
Is this difference in crystallin response unique to these
mice or is it found in other species? Examining the litera-
Quantitative trait locus cluster map of PC3 negative Figure 4
Quantitative trait locus cluster map of PC3 negative. The QTL cluster map for genes in PC3 negative shows potential 
regulatory genomic loci. Horizontal heat maps represent individual genes. There are 38 genes (those above the red line) in the 
PC3 negative network in this heat map; the numbers to the left denote the individual genes. The genes are represented in a 
genome-wide scan with the chromosomal locations at the top of the heat map ranging from Chr 1 on the left to Chr X on the 
right. The yellow, red, and blue bands denote the locations of genomic loci that modulate all of the genes in the network. Note 
that some bands are more prominent than others. The two most prominent bands are in Chr 4, 50105 Mb (A) and Chr 17, 
2740 Mb (B). The network analysis can be taken one step further by identifying candidate genes within the loci, using advanced 
search tools on GeneNetwork. For the regulatory locus on Chr 4 (A) the genes are Ltb4dh, Pole3, Rgs3, Tnc, Ugcg, and Fkbp15. 
A candidate gene for Chr 17(B), Bat1, is from our PC3 negative group. Note that these candidate genes have a QTL structure 
(banding pattern) similar to that of genes within PC3 negative.BMC Neuroscience 2009, 10:90 http://www.biomedcentral.com/1471-2202/10/90
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ture, we found that the response of crystallins in the retina
varies from strain to strain in both mouse and rat. For
example, in Wistar [46] and Brown Norway rats [8], crys-
tallin expression goes down after elevated IOP. In
Sprague-Dawley rats, crystallins are upregulated after
either a retinal tear [7] or after light damage [47]. A similar
story is found for the mouse. In the naturally occurring
glaucoma of the DBA/2J mouse, Steele et al. [48] found
that crystallins are downregulated. In the C57BL/6 mouse,
crystallins are upregulated after laser burns in the retina
[17]. Taken together, these findings clearly demonstrate
different responses of the crystallin family depending on
the strain of rodent as well as different types of insult.
Initially one thinks of crystallins as lens proteins; how-
ever, it is becoming increasingly clear that members of this
family have biological roles outside the lens [47,49-53].
Several studies of the retina have demonstrated a group of
crystallins that are altered by light-induced injury [47],
elevated IOP [8,54], or retinal detachment [16]. Changes
in crystallin expression is also found after injury in other
regions of the CNS, including the spinal cord [55] and cer-
ebral cortex [56]. Selected crystallins also have a function
in the response to injury in non-neuronal tissues such as
heart muscle [57,58] and kidney [59]. Thus, the crystallins
can no longer be thought of as merely lens proteins, but
must be considered as having a larger biological role.
What function do crystallins have in the retina and other
tissues? The α-crystallins possess chaperone activity and
share properties with heat-shock proteins [50,60]. The β-
crystallins and γ-crystallins also respond to stress in tissues
other than the lens and have an AP-1 binding site in their
promoter regions [61]. Most functional studies of crystal-
lins point to an intrinsic action of the proteins affecting
intracellular molecular processes. Specifically, α-crystal-
lins appear to have anti-apoptotic activity [62-66].
Recently, Fischer et al. [67] suggested that purified crystal-
lins added to the vitreous chamber or cultured explants of
retina promote axonal growth and induce reactive gliosis.
In the present study, we observed differential regulation of
crystallin family members following optic nerve crush in
C57BL/6 and DBA/2J mice. It is tempting to speculate that
this differential expression of crystallins may account, in
part, for the differential survival of retinal ganglion cells
after optic nerve crush. This hypothesis is supported in
part by recent studies demonstrating that crystallin family
members protect retinal ganglion cells from the effects of
optic nerve crush [68].
Table 1: Crystallin gene correlation across strains and tissues
Gene Symbol Gene Name Tissue and Database
BXD: Retina BXD: Hippocampus LXS: Hippocampus
Cryaa crystallin, alpha A 0.981 0.940 0.868
Cryba1 crystallin, beta A1 0.998 0.973 0.974
Cryba2 crystallin, beta A2 0.999 0.627 0.988
Cryba4 crystallin, beta A4 0.988 0.844 0.963
Crybb1 crystallin, beta B1 0.953 - 0.579
Crybb2 crystallin, beta B2 0.997 0.899 0.976
Crybb3 crystallin, beta B3 0.952 0.682 0.927
Crygb crystallin, gamma B 0.882 0.913 0.988
Crygc crystallin, gamma C 0.888 0.948 0.960
Crygd crystallin, gamma D 0.858 0.828 0.980
Crygs crystallin, gamma S 1.000 1.000 1.000
The table contains the crystallin genes, which showed the expression pattern due to injury seen in Figure 5. The values represent the correlation 
values in our HEI Retina Database for the BXD RI strain set. The correlation values are also shown for Hippocampus tissues in the BXD RI strain 
set as well as the LXS mouse cross. This demonstrates that the crystallin gene correlation is not limited to the retina or the BXD. Correlation 
values are related to the probe or probe set for Crygs.BMC Neuroscience 2009, 10:90 http://www.biomedcentral.com/1471-2202/10/90
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Inbred mouse strains are powerful tools in defining the
genetic basis for selective susceptibility to neuronal death.
By examining differences in the susceptibility of individ-
ual mouse strains, it is possible to identify the contribu-
tion of genetic background to differential neuronal death.
The genetic backgrounds of inbred strains influence the
response of the retina and CNS to disease and injury. A
prime example of this approach is a paper from the Nick-
ells group [6]. The authors examined neuronal survival
following optic nerve crush in 15 strains of mice, finding
that a substantial difference in neuronal survival
depended on the mouse strain studied. The most resistant
strain was the DBA/2J mouse; the most susceptible was
the BALB/cByJ mouse. The strain hierarchy of the effect of
nerve crush does not translate to other types of CNS neu-
rons. In the spinal cord, neurons in the BALB/c are highly
susceptible to contusion injury [69], whereas neurons of
the substantia nigra in the BALB/c strain are relatively
resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP), as well as experimental autoimmune encephali-
tis (EAE) [49,70,71]. In the C57BL/6J mouse strain, retinal
ganglion cells are comparatively resistant to optic nerve
crush but are susceptible to MPTP exposure and EAE.
Interestingly, the C57BL/6J and BALB/c strains are approx-
imately equal in their susceptibility to spinal cord injury
[69]. Schauwecker and Steward [72] determined that the
C57BL/6J and BALB/c strains are invulnerable to gluta-
mate-induced excitotoxic cell death in the hippocampus.
The complex effects of genetic background on the vulner-
ability of neurons to injury are revealed by each strain's
response, which is also dependent on the specific type of
insult or the CNS region that is injured. We found small
but statistically significant differences between two closely
related strains, the DBA/2J strain and the C57BL/6J strain
[73].
Conclusion
In conclusion, this study defines the differential responses
of the DBA/2J mouse and the C57BL/6J mouse to optic
nerve crush. These include genetic networks that are asso-
ciated with ganglion cell death and reactive gliosis. These
findings from different inbred strains support the notion
that the differential susceptibility of neurons to injury is a
complex genetic trait modulated by several distinct
genomic loci. In fact, several genomic loci have been
mapped in the mouse that modulate the response of neu-
rons to injury [74,75]. The first QTL mapped for neuronal
injury in the mouse, on distal chromosome 1 [76],
implies susceptibility to MPTP-induced death of substan-
tia nigra neurons. Recently, a locus that modulates the
response of retinal ganglion cells to axon damage (optic
nerve crush) was mapped to chromosome 5 [74]. In addi-
tion, a QTL in the hippocampus that modulates excito-
toxic susceptibility to cell death was mapped to distal
chromosome 18. Thus, at least three loci are known that
can modulate the susceptibility of neurons to injury. Each
locus was mapped using different types of neurons (in dif-
ferent region of the CNS) and a different type of insult
(ranging from crushed axons to chemical insult). None-
theless, we can see that different regions of the genome
affect neuronal survival. There is every reason to believe
that this complex trait will include even more loci to pro-
duce specific susceptibility phenotypes among different
strains of mice.
Methods
Mice were used in three separate sets of experiments. We
used 11 C57BL/6J mice and 10 DBA/2J mice between 60
and 90 days of age for anatomical studies to determine the
percentage of neurons surviving after optic nerve crush.
Graph of crystallin genes comparison between the strains  and experimental conditions Figure 5
Graph of crystallin genes comparison between the 
strains and experimental conditions. The relative fold 
changes in selected crystallin mRNA for the C57BL/6J (B6) 
strain (A) and DBA/2J (D2) strain (B) are illustrated. To the 
far right is a legend identifying the specific crystallin family 
members. The members of the crystallin family with this pat-
tern of expression include and significant changes are Cryaa, 
Cryab, Cryba1, Cryba2, Cryba4, Crybb1, Crybb2, Crybb3, 
Crygb, Crygc, Crygd, and Crygs. This was not the case with 
all the crystallin genes. Notice that in general the crystallins 
are more highly expressed in the normal C57BL/6J retina 
than in the normal DBA/2J retina. After injury, the expres-
sion level of the crystallins decrease in the C57BL/6J while in 
the DBA/2J retina the levels increase. Signal is expressed as a 
2 (z-score of log2 [intensity]) + 8.BMC Neuroscience 2009, 10:90 http://www.biomedcentral.com/1471-2202/10/90
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For the microarray studies 9 C57BL/6J mice and 9 DBA/2J
mice from 60 to 90 days of age were used with 3 mice (two
pooled retina samples) for each dataset. The astrocytes
were cultured from 3 C57BL/6J and 3 DBA/2J mice at
postnatal day 3 (P3) to produce six independent samples
of cerebral astrocytes, following procedures detailed by
Geisert and Stewart [77].
Optic nerve crush
Mice were deeply anesthetized with a mixture of 13 mg/kg
of Rompum and 87 mg/kg of Ketalar. A small incision was
made in the lateral aspect of the conjunctiva. With a pair
of small forceps the edge of the conjunctiva next to the
globe was retracted slightly and rotated laterally, allowing
visualization of the posterior aspect of the globe where the
optic nerve could be observed. Viewed under a binocular
operating microscope, the surrounding connective tissue
and muscle was gently separated from the nerve. The
exposed optic nerve was grasped for 10 sec with a pair of
Dumont cross-clamp #7 forceps (Roboz, cat. #RS = 5027,
Gaithersburg, MD). This instrument was chosen because
its spring action applied a moderate yet constant and con-
sistent force to the optic nerve. The forceps were then
removed and the eye was allowed to rotate back into
place. The Animal Use Committee at the University of
Tennessee Health Science Center approved all procedures
for the surgery and handling of mice.
Immunohistochemical Analysis of Retinal Ganglion Cell 
Loss
To evaluate the number of retinal ganglion cells following
optic nerve crush, we used 5 C57BL/6J mice and 5 DBA/2J
mice (8 retinas per strain) as controls. We performed
crush injury to the optic nerve of 6 C57BL/6J mice and 5
DBA/2J mice (12 and 8 retinas, respectively.) We crushed
both nerves on the experimental animals. Several studies
[78,79] have shown that crushing the optic nerve unilat-
erally has measurable effects on the contralateral retina.
For this reason we have chosen to use one group of mice
for optic nerve crush and a second naive set of mice as
controls. The mice receiving optic nerve crush were
allowed to survive for 30 days, after which they were
deeply anesthetized with a mixture of 13 mg/kg of
Rompum and 87 mg/kg of Ketalar, then perfused through
the heart with saline followed by 4% paraformaldehyde
in 0.1 M phosphate buffer (pH 7.3). We post-fixed the
eyes for 24 hours. The next day the retinas were dissected
free from the globe and rinsed in phosphate buffered
saline. The intact retinal cups were placed in citrate buffer
(10 mM sodium citrate, 0.05% Tween 20, pH 6.0) at
90100°C for 20 min. The retinas were extensively rinsed
in PBS, and then placed in 2% bovine serum albumin
(BSA) for 30 min. The retinas were stained with primary
antibodies directed against NeuN (1:250 monoclonal
mouse anti-neuronal nuclei, Millipore, Billerica MA). The
retinas remained in the primary antibodies for two days at
4°C. After three extended rinses in PBS, the retinas were
transferred to secondary antibodies in 2% BSA for two
days. Alexa Fluor 555 donkey anti-mouse IgG (Invitrogen
Molecular Probes, Eugene OR) was used to stain the
NeuN antibody. After rinsing the retinas, four small cuts
were made in each one to assist in the retinal flat mounts.
Each retina was flooded with Fluoromount-G and covered
with a coverslip.
Low-power (4×) photomicrographs of the slides were
taken using the Nikon Eclipse TE2000-E confocal micro-
scope along with 1 mm scale bar. The area of each retina
was calculated using the scale bar and NIH Image-J soft-
ware. To determine the density of ganglion cells in a given
retina, we placed a sampling grid over the 4× image of the
retina in an orientation that maximized fields across all
regions of the retina. Then we photographed the retina at
each of the intersect points in the grid. This resulted in a
minimum of 14 or a maximum of 18 sampling fields per
retina. The NeuN-positive cells in each field were counted
to define the number of ganglion cells per field. We used
the mean number of ganglion cells per field to define the
percent of change in retinal ganglion cells following optic
nerve crush.
Correlation of crystallin genes expression in the normal ret- ina of the BXD RI strain set Figure 6
Correlation of crystallin genes expression in the nor-
mal retina of the BXD RI strain set. The expression pat-
terns of many of the crystallin family members across the 49 
BXD RI strains in the HEI Retina Database are highly corre-
lated. The color of the lines connecting gene symbols indicate 
the degree of expression correlations (see scale at bottom of 
the figure). For these genes the correlation between the 
group is high (r > 0.7).BMC Neuroscience 2009, 10:90 http://www.biomedcentral.com/1471-2202/10/90
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Illumina Microarray Methods
The Illumina Sentrix Mouse-6 BeadChip V1.0 interro-
gated approximately 46,000 sequences from the mouse
transcriptome. We used three samples from each strain
and condition. For each sample, the RNA was pooled
from two retinas. The tissue was homogenized and
extracted according to the RNA-Stat-60 protocol as
described by the manufacturer (Tel-Test, Friendswood,
TX). The quality and purity of RNA was assessed using an
Agilent Bioanalyzer 2100 system. The RNA from each
sample was processed with the Illumina TotalPrep RNA
Amplification Kit (Ambion, Austin, TX) to produce
labeled cRNA. The cRNA for each sample was then hybrid-
ized to an Illumina Sentrix® Mouse-6-V1.0 BeadChip (Illu-
mina, San Diego, CA). A total of three Beadchips were
used for the experiment. The Sentrix Mouse-6-V1 Bead-
Chip contains ~48,000 probe sets directed against approx-
imately 44,000 transcripts. Raw image data was subjected
to quality control analysis using Illumina BeadScan soft-
ware. MIAME standards were used for all microarray data.
The data discussed in this publication have been depos-
ited in NCBI's Gene Expression Omnibus [80] and are
accessible through GEO Series accession number
GSE17117 http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE17117.
Once data was collected from all experimental conditions,
we normalized the data using the formula 2 (z-score of
log2 [intensity]) + 8 as previously described [7,81]. This
procedure sets the mean expression level across a single
microarray to 8 units on an exponential scale similar to
that produced by real-time qRT-PCR. For the microarray
analysis, we compared the changes in the transcriptome of
C57BL/6J mice to that of DBA/2J mice before and after
optic nerve crush. The mice, at 6090 days of age, could be
considered adults with fully developed retinas. At this age
range, DBA/2J mice had not yet developed symptoms
associated with pigmentary dispersion glaucoma. For
each mouse strain, three independent samples were run
for each experimental condition: control retina RNA and
RNA isolated from retinas 2-days and 5-days after optic
nerve crush. The microarray data formed a 2 by 3 experi-
mental comparison; with optic nerve crush representing
one dimension of the comparison and the two mouse
strains representing the other dimension.
To test the quality of the data generated, we selected the
top 100 transcripts with the least change between control
and experimental C57BL/6J mice 2-days after optic nerve
crush. In essence, these transcripts function as 100 house-
keeping genes. When these transcripts are examined
across all six experimental conditions, identical patterns
of expression are observed, with these transcripts
expressed at equivalent levels in C57BL/6J and DBA/2J
mice. The 100 probes were selected from the C57BL/6J
control set as compared to the 2-day injury dataset (r2 =
0.99). Across all of the parametric comparisons within the
group of six conditions, the worst fit for these 100 genes
was between the DBA/2J control and experimental data-
sets and the C57BL/6J 5-days after optic nerve crush data-
set. In this case, the bivariate correlation was still high (r2
= 0.68). The quality and stability of this dataset is
extremely good. There was no change between animals in
probes recognizing low levels of expression (a value of 7
on our scale, which represents 1 log2, 2-fold, below the
mean expression level) or probes having high levels of
expression (a value of 16 on our scale, which represents 8
log2, 128-fold, above the mean expression level).
We used Significance Analysis of Microarrays (Signifi-
cance Analysis of microarrays [SAM] v3.0 Stanford Uni-
versity, http://www-stat.stanford.edu/~tibs/SAM) to
calculate a list of transcripts we considered to be differen-
tially expressed across our datasaet. We examined differ-
ences between the control samples and between the
controls and either 2 days after injury or 5 days after injury
for each strain. All of the transcripts had a false discovery
rate below 0.03. The duplicates were scrubbed resulting in
a final 1580 genes. The 1,580 SAM significant transcripts
were entered into CLUSFAVOR 6.0 (Departments of Med-
icine, Molecular and Human Genetics, and Scott Depart-
ment of Urology, Baylor College of Medicine, Houston,
TX) for pattern analysis.
Microarray Confirmation Through Real-Time qRT-PCR
Selected genes from the microarray datasets, including
Bcl2a1a, Chrna6, Cryaa, Cryba2, Crybb2, Crym, Egr1, Gfap,
Lpin1, Rho, Sag, Sox11, and Thy1 as well as Actb as a con-
trol, were validated using real-time qRT-PCR, which was
done on the Roche LightCycler 480 system (F. Hoffmann-
La Roche, Switzerland). To normalize the data, Actb was
run as a housekeeping gene. Each gene was run under 5
concentrations in duplicate along with negative control,
neg-RT, as well as water for controls. Assays were designed
on the Roche web site [82]. The primers were synthesized
by Integrated DNA Technologies (See additional file 4:
Oligonucleotides used for Real-Time qRT-PCR).
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